Kareem Reda is a member of the Board of Directors and an Advisor at 64x Bio. Kareem is also the Founder and Managing Partner of HilmBio Advisory where he advises biotech companies on corporate strategy, venture financing, and business development.

‍

He was previously Chief Business Officer at ElevateBio where he led and executed multiple strategic long-term partnerships including collaborations with Moderna and Novo Nordisk. Prior to joining ElevateBio, Kareem was the Head of Business Development and Corporate Strategy at Evelo Biosciences. He played an integral role in the company’s $85 million initial public offering and private Series B and C fundraising rounds, helping to raise over $200 million. Kareem previously worked at Celgene in business development where he executed over a dozen deals with a total value greater than $5 billion. Notably, Kareem led the B-cell maturation antigen (BCMA) collaboration with bluebird bio and the $1 billion, 10-year collaboration with Juno Therapeutics. He began his career at Vertex Pharmaceuticals.

‍

Kareem graduated magna cum laude with a degree in Chemical Engineering from Brown University and received an MBA from Harvard Business School. In 2021, he was named to Boston Business Journal’s 40 under 40 and has contributed to the development or acquisition of six FDA approved therapies.